1 Market Overview

1.1 Drug–Device Combination Products Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Drug–Device Combination Products Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Infusion Pumps

1.2.3 Orthopedic Combination Products

1.2.4 Photodynamic Therapy Devices

1.2.5 Transdermal Patches

1.2.6 Drug Eluting Stents

1.2.7 Wound Care Products

1.2.8 Inhalers

1.2.9 Other

1.3 Market Analysis by Application

1.3.1 Overview: Global Drug–Device Combination Products Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Overview of Global Drug–Device Combination Products Market

1.4.1 Global Drug–Device Combination Products Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott SWOT Analysis

2.1.4 Abbott Product and Services

2.1.5 Abbott Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis SWOT Analysis

2.2.4 Novartis Product and Services

2.2.5 Novartis Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Mylan

2.3.1 Mylan Details

2.3.2 Mylan Major Business

2.3.3 Mylan SWOT Analysis

2.3.4 Mylan Product and Services

2.3.5 Mylan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Terumo Corporation

2.4.1 Terumo Corporation Details

2.4.2 Terumo Corporation Major Business

2.4.3 Terumo Corporation SWOT Analysis

2.4.4 Terumo Corporation Product and Services

2.4.5 Terumo Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Boston Scientific

2.5.1 Boston Scientific Details

2.5.2 Boston Scientific Major Business

2.5.3 Boston Scientific SWOT Analysis

2.5.4 Boston Scientific Product and Services

2.5.5 Boston Scientific Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Stryker Corporation

2.6.1 Stryker Corporation Details

2.6.2 Stryker Corporation Major Business

2.6.3 Stryker Corporation Product and Services

2.6.4 Stryker Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Teleflex Incorporated

2.7.1 Teleflex Incorporated Details

2.7.2 Teleflex Incorporated Major Business

2.7.3 Teleflex Incorporated Product and Services

2.7.4 Teleflex Incorporated Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Allergan

2.8.1 Allergan Details

2.8.2 Allergan Major Business

2.8.3 Allergan Product and Services

2.8.4 Allergan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Medtronic

2.9.1 Medtronic Details

2.9.2 Medtronic Major Business

2.9.3 Medtronic Product and Services

2.9.4 Medtronic Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 BD

2.10.1 BD Details

2.10.2 BD Major Business

2.10.3 BD Product and Services

2.10.4 BD Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Drug–Device Combination Products Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Drug–Device Combination Products Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Drug–Device Combination Products Manufacturer Market Share in 2019

3.3.2 Top 6 Drug–Device Combination Products Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Drug–Device Combination Products Sales, Revenue and Market Share by Regions

4.1.1 Global Drug–Device Combination Products Sales and Market Share by Regions (2015-2020)

4.1.2 Global Drug–Device Combination Products Revenue and Market Share by Regions (2015-2020)

4.2 North America Drug–Device Combination Products Sales and Growth Rate (2015-2020)

4.3 Europe Drug–Device Combination Products Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Drug–Device Combination Products Sales and Growth Rate (2015-2020)

4.5 South America Drug–Device Combination Products Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Drug–Device Combination Products Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Drug–Device Combination Products Sales, Revenue and Market Share by Country

5.1.1 North America Drug–Device Combination Products Sales and Market Share by Country (2015-2020)

5.1.2 North America Drug–Device Combination Products Revenue and Market Share by Country (2015-2020)

5.2 United States Drug–Device Combination Products Sales and Growth Rate (2015-2020)

5.3 Canada Drug–Device Combination Products Sales and Growth Rate (2015-2020)

5.4 Mexico Drug–Device Combination Products Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Drug–Device Combination Products Sales, Revenue and Market Share by Country

6.1.1 Europe Drug–Device Combination Products Sales and Market Share by Country (2015-2020)

6.1.2 Europe Drug–Device Combination Products Revenue and Market Share by Country (2015-2020)

6.2 Germany Drug–Device Combination Products Sales and Growth Rate (2015-2020)

6.3 UK Drug–Device Combination Products Sales and Growth Rate (2015-2020)

6.4 France Drug–Device Combination Products Sales and Growth Rate (2015-2020)

6.5 Russia Drug–Device Combination Products Sales and Growth Rate (2015-2020)

6.6 Italy Drug–Device Combination Products Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Drug–Device Combination Products Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Drug–Device Combination Products Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Drug–Device Combination Products Revenue and Market Share by Regions (2015-2020)

7.2 China Drug–Device Combination Products Sales and Growth Rate (2015-2020)

7.3 Japan Drug–Device Combination Products Sales and Growth Rate (2015-2020)

7.4 Korea Drug–Device Combination Products Sales and Growth Rate (2015-2020)

7.5 India Drug–Device Combination Products Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Drug–Device Combination Products Sales and Growth Rate (2015-2020)

7.7 Australia Drug–Device Combination Products Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Drug–Device Combination Products Sales, Revenue and Market Share by Country

8.1.1 South America Drug–Device Combination Products Sales and Market Share by Country (2015-2020)

8.1.2 South America Drug–Device Combination Products Revenue and Market Share by Country (2015-2020)

8.2 Brazil Drug–Device Combination Products Sales and Growth Rate (2015-2020)

8.3 Argentina Drug–Device Combination Products Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Drug–Device Combination Products Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Drug–Device Combination Products Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Drug–Device Combination Products Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Drug–Device Combination Products Sales and Growth Rate (2015-2020)

9.3 Turkey Drug–Device Combination Products Sales and Growth Rate (2015-2020)

9.4 Egypt Drug–Device Combination Products Sales and Growth Rate (2015-2020)

9.5 South Africa Drug–Device Combination Products Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Drug–Device Combination Products Sales and Market Share by Type (2015-2020)

10.2 Global Drug–Device Combination Products Revenue and Market Share by Type (2015-2020)

10.3 Global Drug–Device Combination Products Price by Type (2015-2020)

11 Global Drug–Device Combination Products Market Segment by Application

11.1 Global Drug–Device Combination Products Sales Market Share by Application (2015-2020)

11.2 Global Drug–Device Combination Products Revenue Market Share by Application (2015-2020)

11.3 Global Drug–Device Combination Products Price by Application (2015-2020)

12 Market Forecast

12.1 Global Drug–Device Combination Products Sales, Revenue and Growth Rate (2021-2025)

12.2 Drug–Device Combination Products Market Forecast by Regions (2021-2025)

12.2.1 North America Drug–Device Combination Products Market Forecast (2021-2025)

12.2.2 Europe Drug–Device Combination Products Market Forecast (2021-2025)

12.2.3 Asia-Pacific Drug–Device Combination Products Market Forecast (2021-2025)

12.2.4 South America Drug–Device Combination Products Market Forecast (2021-2025)

12.2.5 Middle East & Africa Drug–Device Combination Products Market Forecast (2021-2025)

12.3 Drug–Device Combination Products Market Forecast by Type (2021-2025)

12.3.1 Global Drug–Device Combination Products Sales Forecast by Type (2021-2025)

12.3.2 Global Drug–Device Combination Products Market Share Forecast by Type (2021-2025)

12.4 Drug–Device Combination Products Market Forecast by Application (2021-2025)

12.4.1 Global Drug–Device Combination Products Sales Forecast by Application (2021-2025)

12.4.2 Global Drug–Device Combination Products Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables

Table 1. Global Drug–Device Combination Products Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Drug–Device Combination Products by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Drug–Device Combination Products Market Size and Growth Estimation in Various Scenarios in 2020

Table 4. Global Drug–Device Combination Products Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 5. Market Opportunities in Next Few Years

Table 6. Market Risks Analysis

Table 7. Market Drivers

Table 8. Abbott Basic Information, Manufacturing Base and Competitors

Table 9. Abbott Drug–Device Combination Products Major Business

Table 10. Abbott Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 11. Abbott SWOT Analysis

Table 12. Abbott Drug–Device Combination Products Product and Services

Table 13. Abbott Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 14. Novartis Basic Information, Manufacturing Base and Competitors

Table 15. Novartis Drug–Device Combination Products Major Business

Table 16. Novartis Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 17. Novartis SWOT Analysis

Table 18. Novartis Drug–Device Combination Products Product and Services

Table 19. Novartis Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 20. Mylan Basic Information, Manufacturing Base and Competitors

Table 21. Mylan Drug–Device Combination Products Major Business

Table 22. Mylan Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 23. Mylan SWOT Analysis

Table 24. Mylan Drug–Device Combination Products Product and Services

Table 25. Mylan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 26. Terumo Corporation Basic Information, Manufacturing Base and Competitors

Table 27. Terumo Corporation Drug–Device Combination Products Major Business

Table 28. Terumo Corporation Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 29. Terumo Corporation SWOT Analysis

Table 30. Terumo Corporation Drug–Device Combination Products Product and Services

Table 31. Terumo Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 32. Boston Scientific Basic Information, Manufacturing Base and Competitors

Table 33. Boston Scientific Drug–Device Combination Products Major Business

Table 34. Boston Scientific Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 35. Boston Scientific SWOT Analysis

Table 36. Boston Scientific Drug–Device Combination Products Product and Services

Table 37. Boston Scientific Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 38. Stryker Corporation Basic Information, Manufacturing Base and Competitors

Table 39. Stryker Corporation Drug–Device Combination Products Major Business

Table 40. Stryker Corporation Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 41. Stryker Corporation SWOT Analysis

Table 42. Stryker Corporation Drug–Device Combination Products Product and Services

Table 43. Stryker Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 44. Teleflex Incorporated Basic Information, Manufacturing Base and Competitors

Table 45. Teleflex Incorporated Drug–Device Combination Products Major Business

Table 46. Teleflex Incorporated Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 47. Teleflex Incorporated SWOT Analysis

Table 48. Teleflex Incorporated Drug–Device Combination Products Product and Services

Table 49. Teleflex Incorporated Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 50. Allergan Basic Information, Manufacturing Base and Competitors

Table 51. Allergan Drug–Device Combination Products Major Business

Table 52. Allergan Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 53. Allergan SWOT Analysis

Table 54. Allergan Drug–Device Combination Products Product and Services

Table 55. Allergan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 56. Medtronic Basic Information, Manufacturing Base and Competitors

Table 57. Medtronic Drug–Device Combination Products Major Business

Table 58. Medtronic Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 59. Medtronic SWOT Analysis

Table 60. Medtronic Drug–Device Combination Products Product and Services

Table 61. Medtronic Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 62. BD Basic Information, Manufacturing Base and Competitors

Table 63. BD Drug–Device Combination Products Major Business

Table 64. BD Drug–Device Combination Products Total Revenue (USD Million) (2018-2019)

Table 65. BD SWOT Analysis

Table 66. BD Drug–Device Combination Products Product and Services

Table 67. BD Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 68. Global Drug–Device Combination Products Sales by Manufacturer (2018-2019) (K Units)

Table 69. Global Drug–Device Combination Products Revenue by Manufacturer (2018-2019) (USD Million)

Table 70. Global Drug–Device Combination Products Sales by Regions (2015-2020) (K Units)

Table 71. Global Drug–Device Combination Products Sales Market Share by Regions (2015-2020)

Table 72. Global Drug–Device Combination Products Revenue by Regions (2015-2020) (USD Million)

Table 73. North America Drug–Device Combination Products Sales by Countries (2015-2020) (K Units)

Table 74. North America Drug–Device Combination Products Sales Market Share by Countries (2015-2020)

Table 75. North America Drug–Device Combination Products Revenue by Countries (2015-2020) (USD Million)

Table 76. North America Drug–Device Combination Products Revenue Market Share by Countries (2015-2020)

Table 77. Europe Drug–Device Combination Products Sales by Countries (2015-2020) (K Units)

Table 78. Europe Drug–Device Combination Products Sales Market Share by Countries (2015-2020)

Table 79. Europe Drug–Device Combination Products Revenue by Countries (2015-2020) (USD Million)

Table 80. Asia-Pacific Drug–Device Combination Products Sales by Regions (2015-2020) (K Units)

Table 81. Asia-Pacific Drug–Device Combination Products Sales Market Share by Regions (2015-2020)

Table 82. Asia-Pacific Drug–Device Combination Products Revenue by Regions (2015-2020) (USD Million)

Table 83. South America Drug–Device Combination Products Sales by Countries (2015-2020) (K Units)

Table 84. South America Drug–Device Combination Products Sales Market Share by Countries (2015-2020)

Table 85. South America Drug–Device Combination Products Revenue by Countries (2015-2020) (USD Million)

Table 86. South America Drug–Device Combination Products Revenue Market Share by Countries (2015-2020)

Table 87. Middle East & Africa Drug–Device Combination Products Sales by Countries (2015-2020) (K Units)

Table 88. Middle East & Africa Drug–Device Combination Products Sales Market Share by Countries (2015-2020)

Table 89. Middle East & Africa Drug–Device Combination Products Revenue by Countries (2015-2020) (USD Million)

Table 90. Middle East & Africa Drug–Device Combination Products Revenue Market Share by Countries (2015-2020)

Table 91. Global Drug–Device Combination Products Sales by Type (2015-2020) (K Units)

Table 92. Global Drug–Device Combination Products Sales Share by Type (2015-2020)

Table 93. Global Drug–Device Combination Products Revenue by Type (2015-2020) (USD Million)

Table 94. Global Drug–Device Combination Products Revenue Share by Type (2015-2020)

Table 95. Global Drug–Device Combination Products Sales by Application (2015-2020) (K Units)

Table 96. Global Drug–Device Combination Products Sales Share by Application (2015-2020)

Table 97. Global Drug–Device Combination Products Sales Forecast by Regions (2021-2025) (K Units)

Table 98. Global Drug–Device Combination Products Market Share Forecast by Regions (2021-2025)

Table 99. Global Drug–Device Combination Products Sales Forecast by Type (2021-2025) (K Units)

Table 100. Global Drug–Device Combination Products Market Share Forecast by Type (2021-2025)

Table 101. Global Drug–Device Combination Products Sales Forecast by Application (2021-2025)

Table 102. Global Drug–Device Combination Products Market Share Forecast by Application (2021-2025)

Table 103. Direct Channel Pros & Cons

Table 104. Indirect Channel Pros & Cons

Table 105. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Drug–Device Combination Products Picture

Figure 2. Global Sales Market Share of Drug–Device Combination Products by Type in 2019

Figure 3. Infusion Pumps Picture

Figure 4. Orthopedic Combination Products Picture

Figure 5. Photodynamic Therapy Devices Picture

Figure 6. Transdermal Patches Picture

Figure 7. Drug Eluting Stents Picture

Figure 8. Wound Care Products Picture

Figure 9. Inhalers Picture

Figure 10. Other Picture

Figure 11. Drug–Device Combination Products Sales Market Share by Application in 2019

Figure 12. Hospital Picture

Figure 13. Clinic Picture

Figure 14. Other Picture

Figure 15. Global Drug–Device Combination Products Market Status and Outlook (2015-2025) (USD Million)

Figure 16. United States Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 17. Canada Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 18. Mexico Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 19. Germany Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 20. France Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 21. UK Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 22. Russia Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 23. Italy Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 24. China Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 25. Japan Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 26. Korea Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 27. India Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 28. Southeast Asia Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 29. Australia Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 30. Brazil Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 31. Egypt Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 32. Saudi Arabia Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 33. South Africa Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 34. Turkey Drug–Device Combination Products Revenue (Value) and Growth Rate (2015-2025)

Figure 35. Global Drug–Device Combination Products Sales Market Share by Manufacturer in 2019

Figure 36. Global Drug–Device Combination Products Revenue Market Share by Manufacturer in 2019

Figure 37. Top 3 Drug–Device Combination Products Manufacturer (Revenue) Market Share in 2019

Figure 38. Top 6 Drug–Device Combination Products Manufacturer (Revenue) Market Share in 2019

Figure 39. Key Manufacturer Market Share Trend

Figure 40. Global Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 41. Global Drug–Device Combination Products Revenue and Growth Rate (2015-2020) (USD Million)

Figure 42. Global Drug–Device Combination Products Revenue Market Share by Regions (2015-2020)

Figure 43. Global Drug–Device Combination Products Revenue Market Share by Regions in 2018

Figure 44. North America Drug–Device Combination Products Sales and Growth Rate (2015-2020)

Figure 45. Europe Drug–Device Combination Products Sales and Growth Rate (2015-2020)

Figure 46. Asia-Pacific Drug–Device Combination Products Sales and Growth Rate (2015-2020)

Figure 47. South America Drug–Device Combination Products Sales and Growth Rate (2015-2020)

Figure 48. Middle East & Africa Drug–Device Combination Products Sales and Growth Rate (2015-2020)

Figure 49. North America Drug–Device Combination Products Revenue and Growth Rate (2015-2020) (USD Million)

Figure 50. North America Drug–Device Combination Products Sales Market Share by Countries (2015-2020)

Figure 51. North America Drug–Device Combination Products Sales Market Share by Countries in 2018

Figure 52. North America Drug–Device Combination Products Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 53. North America Drug–Device Combination Products Revenue Market Share by Countries in 2018

Figure 54. United States Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 55. Canada Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 56. Mexico Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 57. Europe Drug–Device Combination Products Revenue and Growth Rate (2015-2020) (USD Million)

Figure 58. Europe Drug–Device Combination Products Revenue Market Share by Countries (2015-2020)

Figure 59. Europe Drug–Device Combination Products Revenue Market Share by Countries in 2019

Figure 60. Germany Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 61. UK Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 62. France Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 63. Russia Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 64. Italy Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 65. Asia-Pacific Drug–Device Combination Products Revenue and Growth Rate (2015-2020) (USD Million)

Figure 66. Asia-Pacific Drug–Device Combination Products Sales Market Share by Regions 2019

Figure 67. Asia-Pacific Drug–Device Combination Products Revenue Market Share by Regions 2019

Figure 68. China Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 69. Japan Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 70. Korea Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 71. India Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 72. Southeast Asia Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 73. South America Drug–Device Combination Products Revenue and Growth Rate (2015-2020) (USD Million)

Figure 74. South America Drug–Device Combination Products Sales Market Share by Countries in 2019

Figure 75. South America Drug–Device Combination Products Revenue Market Share by Countries in 2019

Figure 76. Brazil Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 77. Argentina Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 78. Middle East and Africa Drug–Device Combination Products Revenue and Growth Rate (2015-2020) (USD Million)

Figure 79. Middle East and Africa Drug–Device Combination Products Sales Market Share by Countries in 2019

Figure 80. Middle East and Africa Drug–Device Combination Products Revenue Market Share by Countries (2015-2020)

Figure 81. Middle East and Africa Drug–Device Combination Products Revenue Market Share by Countries in 2019

Figure 82. Saudi Arabia Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 83. Egypt Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 84. Turkey Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 85. South Africa Drug–Device Combination Products Sales and Growth Rate (2015-2020) (K Units)

Figure 86. Global Drug–Device Combination Products Sales and Growth Rate (2021-2025) (K Units)

Figure 87. Global Drug–Device Combination Products Revenue and Growth Rate (2021-2025) (USD Million)

Figure 88. North America Sales Drug–Device Combination Products Market Forecast (2021-2025) (K Units)

Figure 89. Europe Sales Drug–Device Combination Products Market Forecast (2021-2025) (K Units)

Figure 90. Asia-Pacific Sales Drug–Device Combination Products Market Forecast (2021-2025) (K Units)

Figure 91. South America Sales Drug–Device Combination Products Market Forecast (2021-2025) (K Units)

Figure 92. Middle East & Africa Sales Drug–Device Combination Products Market Forecast (2021-2025) (K Units)

Figure 93. Sales Channel: Direct Channel vs Indirect Channel